trending Market Intelligence /marketintelligence/en/news-insights/trending/bW90VTskgX08eZkkgda5Yw2 content esgSubNav
In This List

Kubota Pharmaceutical to terminate SEC filing obligations

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Kubota Pharmaceutical to terminate SEC filing obligations

Kubota Pharmaceutical Holdings Co., Ltd. plans to terminate its reporting obligations with the U.S. Securities and Exchange Commission.

The Tokyo-based clinical stage ophthalmology company plans to file a Form 15F with the SEC and the obligations will be suspended 90 days after that.

The administrative burden and costs associated with being a U.S. reporting company outweigh the benefits, the company said a news release.

Kubota will continue to its filings with Japanese securities regulators and its common shares will continue to trade on the Tokyo Stock Exchange.